Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / NGENF - NervGen Pharma appoints Michael Kelly as President & CEO

NGENF - NervGen Pharma appoints Michael Kelly as President & CEO

NervGen Pharma Corp

2023-04-10 09:13:30 ET

  • NervGen Pharma ( OTCQX:NGENF ) has announced the appointment of Mr. Michael Kelly to the position of President & CEO effective April 10, 2023.
  • Mr. Kelly has also been appointed as a member of NervGen's Board of Directors.
  • Mr. Kelly currently serves on the Board of Directors of ARS Pharmaceuticals, which he joined in May 2019.

For further details see:

NervGen Pharma appoints Michael Kelly as President & CEO
Stock Information
Company Name: NervGen Pharma Corp
Stock Symbol: NGENF
Market: OTC
Website: nervgen.com
Menu
NGENF NGENF Quote NGENF Short NGENF News NGENF Articles NGENF Message Board
Get NGENF Alerts

News, Short Squeeze, Breakout and More Instantly...